There’s no doubt that bioprinting, along with various other medial applications within the the 3D printing space will change medicine significantly over the coming decades. We’ve seen tremendous progress being made across the board from 3D printed medical implants to 3D printed human tissue and prostheses which have helped thousands of individuals live fuller, more productive lives.
Back in March, we reported on a Chinese company called Xi’an Particle Cloud Advanced Materials Technology Co., Ltd., who had been making significant advancements in the development of a technique to 3D print bone implants. Back in March, after 5 years of R&D, Xi’an Particle Cloud announced that they had completed successful animal testing at the Department of Orthopedic Surgery in Xijin Hospital, on their 3D printed artificial bones. Using a printing process they call Filament Free Printing (FFP), the company is able to fabricate intricate bone structures which are completely biodegradable. When inserted into a rabbit’s body, the bone almost immediately began growing new cells on its surface, thus proving to be a success in treating bone loss and damage.
Now the company is targeting investors who could help them more rapidly bring this process to market, as well as human clinical trials which are scheduled for later this month and into June.
To read more, click here.